Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Otsuka, Takaharu; Abe, Takashi*; Yoshida, Toru*; Tsunoda, Yusuke*; Shimizu, Noritaka*; Itagaki, Naoyuki*; Utsuno, Yutaka; Vary, J. P.*; Maris, P.*; Ueno, Hideki*
Nature Communications (Internet), 13, p.2234_1 - 2234_10, 2022/04
Times Cited Count:9 Percentile:93.64(Multidisciplinary Sciences)no abstracts in English
Maezawa, Yu*; Maruyama, Toshiki; Itagaki, Naoyuki*; Hatsuda, Tetsuo*
Acta Physica Hungarica A, 22(1-2), p.61 - 68, 2005/00
Times Cited Count:2 Percentile:23.65(Physics, Nuclear)no abstracts in English
Sano, Aaru; Maeda, Shigetaka; Itagaki, Wataru; Sasaki, Shinji; Sasaki, Yuto*; Takaki, Naoyuki*
no journal, ,
Ac-225 is attracting attention as an alpha emitting medical radioisotope. Since its demand is expected to increase, domestic production of Ac-225 is required from the viewpoint of medical research and economic security of Japan. To establish the technical bases for the Ac-225 production, JAEA has evaluated the radioactivity can be produced in the experimental fast reactor Joyo and designed the concept that upgrades the existing facilities for transporting the irradiated target from Joyo to a neighboring PIE facility rapidly. This study has revealed that Joyo can sufficiently produce Ac-225 as a raw material for pharmaceuticals.
Sasaki, Yuto; Sano, Aaru; Itagaki, Wataru; Maeda, Shigetaka; Takaki, Naoyuki*
no journal, ,
no abstracts in English